Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Is MongoDB's Expanding Partner Ecosystem a Sign of further Upside?
Is MongoDB's Expanding Partner Ecosystem a Sign of further Upside?

MongoDB's MDB expanding AI partner ecosystem has become a key catalyst as the platform gains broader industry pull. MDB has added well-known ecosystem partners, including LangChain, Temporal and

GitLab vs. Atlassian: Which DevOps Stock Should Investors Buy Now?
GitLab vs. Atlassian: Which DevOps Stock Should Investors Buy Now?

GitLab GTLB and Atlassian TEAM sit at the center of the enterprise DevSecOps and software-workflow landscape. Both platforms help engineering teams plan, build, secure and ship software at scale

3 Reasons Why Growth Investors Shouldn't Overlook Idexx (IDXX)
3 Reasons Why Growth Investors Shouldn't Overlook Idexx (IDXX)

Investors seek growth stocks to capitalize on above-average growth in financials that help these securities grab the market's attention and produce exceptional returns. But finding a great growth

3 Reasons Why Growth Investors Shouldn't Overlook Commercial Metals (CMC)
3 Reasons Why Growth Investors Shouldn't Overlook Commercial Metals (CMC)

Investors seek growth stocks to capitalize on above-average growth in financials that help these securities grab the market's attention and produce exceptional returns. But finding a great growth

Looking for a Growth Stock? 3 Reasons Why Ensign Group (ENSG) is a Solid Choice
Looking for a Growth Stock? 3 Reasons Why Ensign Group (ENSG) is a Solid Choice

Investors seek growth stocks to capitalize on above-average growth in financials that help these securities grab the market's attention and produce exceptional returns. However, it isn't easy to

3 Reasons Growth Investors Will Love Flowserve (FLS)
3 Reasons Growth Investors Will Love Flowserve (FLS)

Investors seek growth stocks to capitalize on above-average growth in financials that help these securities grab the market's attention and produce exceptional returns. But finding a great growth

3 Reasons Growth Investors Will Love Interface (TILE)
3 Reasons Growth Investors Will Love Interface (TILE)

Investors seek growth stocks to capitalize on above-average growth in financials that help these securities grab the market's attention and produce exceptional returns. However, it isn't easy to

3 Reasons Growth Investors Will Love Tencent (TCEHY)
3 Reasons Growth Investors Will Love Tencent (TCEHY)

Growth investors focus on stocks that are seeing above-average financial growth, as this feature helps these securities garner the market's attention and deliver solid returns. But finding a growth

Here is Why Growth Investors Should Buy CSW Industrials (CSW) Now
Here is Why Growth Investors Should Buy CSW Industrials (CSW) Now

Investors seek growth stocks to capitalize on above-average growth in financials that help these securities grab the market's attention and produce exceptional returns. But finding a great growth

Here is Why Growth Investors Should Buy Federal Signal (FSS) Now
Here is Why Growth Investors Should Buy Federal Signal (FSS) Now

Growth investors focus on stocks that are seeing above-average financial growth, as this feature helps these securities garner the market's attention and deliver solid returns. But finding a great

Affirm Just Crushed Earnings—But Can It Outrun Klarna’s Scale?: https://www.marketbeat.com/logos/articles/med_20251120121555_affirm-just-crushed-earningsbut-can-it-outrun-klar.jpg
Affirm Just Crushed Earnings—But Can It Outrun Klarna’s Scale?

Within the universe of buy-now-pay-later (BNPL) companies, Affirm (NASDAQ: AFRM) has clearly established itself as a leader. It is growing faster than other key players like Klarna (NYSE: KLAR)

ZIM Q3 Earnings & Revenues Miss Estimates, Down Y/Y, 2025 View Updated
ZIM Q3 Earnings & Revenues Miss Estimates, Down Y/Y, 2025 View Updated

ZIM Integrated Shipping Services Ltd. (ZIM) reported disappointing third-quarter 2025 results, wherein both earnings and revenues missed the Zacks Consensus Estimate as well as declined on a

Steady Reward: Is Marsh & McLennan a Keeper or Just Comfortable?
Steady Reward: Is Marsh & McLennan a Keeper or Just Comfortable?

Marsh & McLennan Companies, Inc. MMC appears positioned for meaningful growth, supported by momentum in its Consulting segment, especially Mercer and Oliver Wyman. Improving earnings expectations

Caterpillar vs. Deere: Which Equipment Stock is the Better Buy Now?
Caterpillar vs. Deere: Which Equipment Stock is the Better Buy Now?

Caterpillar Inc. CAT and Deere & Company DE remain two of the most influential names in heavy machinery. Caterpillar, best known for its signature yellow equipment, serves a wide range of

Deere Ready to Report Q4 Earnings: Here's What to Expect for the Stock
Deere Ready to Report Q4 Earnings: Here's What to Expect for the Stock

Deere & Company DE is scheduled to report fourth-quarter fiscal 2025 results on Nov. 26 before the opening bell.

The Zacks Consensus Estimate for Deere’s earnings has moved down 0.3% over the past

Can GigaCloud Technology Inc. (GCT) Run Higher on Rising Earnings Estimates?
Can GigaCloud Technology Inc. (GCT) Run Higher on Rising Earnings Estimates?

GigaCloud Technology Inc. (GCT) appears an attractive pick given a noticeable improvement in the company's earnings outlook. The stock has been a strong performer lately, and the momentum might

Will AmEx's Travel & Lifestyle Services Become Its Next Profit Engine?
Will AmEx's Travel & Lifestyle Services Become Its Next Profit Engine?

American Express Company AXP, popularly known as AmEx, is quietly transforming its travel and lifestyle services offerings into a much bigger growth engine than most people realize. These have

3 AI Infrastructure Stocks on Sale Right Now
3 AI Infrastructure Stocks on Sale Right Now
  • (0:15) - Is It Too Late To Invest Into AI Infrastructure?
  • (2:30) - Tracey’s Top Stock Picks For Your Watchlist Right Now
  • (17:20) - Episode Roundup: STRL, ETN, VRT
  •                 [email protected]
Autodesk to Report Q3 Earnings: What's in the Cards for the Stock?
Autodesk to Report Q3 Earnings: What's in the Cards for the Stock?

Autodesk ADSK is scheduled to release third-quarter fiscal 2026 results on Nov. 25.ADSK expects third-quarter fiscal 2026 revenues to range from $1.80 billion to $1.81 billion.The Zacks Consensus

Research Solutions (RSSS) Upgraded to Strong Buy: Here's Why
Research Solutions (RSSS) Upgraded to Strong Buy: Here's Why

Investors might want to bet on Research Solutions Inc. (RSSS), as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). This rating change essentially reflects an upward trend in earnings

All You Need to Know About Bilibili (BILI) Rating Upgrade to Buy
All You Need to Know About Bilibili (BILI) Rating Upgrade to Buy

Investors might want to bet on Bilibili (BILI), as it has been recently upgraded to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting stock

Ekso Bionics (EKSO) Upgraded to Buy: Here's Why
Ekso Bionics (EKSO) Upgraded to Buy: Here's Why

Ekso Bionics (EKSO) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is one of

Merit Medical (MMSI) Upgraded to Buy: What Does It Mean for the Stock?
Merit Medical (MMSI) Upgraded to Buy: What Does It Mean for the Stock?

Merit Medical (MMSI) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting

Boston Scientific (BSX) Upgraded to Buy: Here's What You Should Know
Boston Scientific (BSX) Upgraded to Buy: Here's What You Should Know

Boston Scientific (BSX) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates --

National Health Investors (NHI) Moves to Buy: Rationale Behind the Upgrade
National Health Investors (NHI) Moves to Buy: Rationale Behind the Upgrade

National Health Investors (NHI) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates